Abbott plans to separate its Nutrition business into a standalone public company. The reported rationale is to shift Abbott’s focus further toward medical technology and diagnostics. The article says the separation would alter Abbott’s cash flow mix, capital allocation, and growth profile, but provides no transaction value or timetable.
Key facts
Abbott Laboratories plans to separate its Nutrition business into a standalone public company. source
Abbott Laboratories plans to shift its focus further towards medical technology and diagnostics as part of its Nutrition business separation. source